
GlaxoSmithKline has had to recall more than 427,000 tubes of creams and ointments due to potential penicillin cross-contamination and the …

Sanofi is gearing up for significant expansion of its inhaler production complex in Cheshire, England. The French pharma giant has …

AstraZeneca has bolstered its US presence with the purchase of a high-tech biologics manufacturing facility from pharma rival Amgen. The …
GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …

Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …

Allergan has issued a recall for batches of eye ointments sold in the US, after customers complained of foreign bodies …

The FDA has served Mylan with a warning letter citing contamination at three of its manufacturing facilities in India. Inspections …

GSK has temporarily shut down its manufacturing site in North Carolina due to the discovery of the bacteria which causes …

The global pharmaceutical contract manufacturing market was worth $58 billion in 2014 and is projected to reach $84 billion in 2020, according to a …

The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a …

Indian drug manufacturer Lupin is expanding to the US by purchasing Gavis pharma for $880 million, in a major boost …
Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …

The FDA has blocked US imports from the manufacturing plants of a major Indian pharmaceutical firm over safety fears. The …

Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …

Actavis is voluntarily recalling more than half a million boxes of contraceptive pills in the United States due to problems …